Search results for "Cancer de la prostate"

showing 6 items of 6 documents

Artificial intelligence for image-guided prostate brachytherapy procedures

2020

Radiotherapy procedures aim at exposing cancer cells to ionizing radiation. Permanently implanting radioactive sources near to the cancer cells is a typical technique to cure early-stage prostate cancer. It involves image acquisition of the patient, delineating the target volumes and organs at risk on different medical images, treatment planning, image-guided radioactive seed delivery, and post-implant evaluation. Artificial intelligence-based medical image analysis can benefit radiotherapy procedures. It can help to facilitate and improve the efficiency of the procedures by automatically segmenting target organs and extrapolating clinically relevant information. However, manual delineation…

Apprentissage profondProstate cancerBrachytherapy[INFO.INFO-IM] Computer Science [cs]/Medical ImagingDeep learningDosimétrieApprentissage automatiqueMedical image segmentationCancer de la prostateDosimetryCuriethérapieMachine learning[INFO.INFO-IM]Computer Science [cs]/Medical ImagingSegmentation d'images médicales
researchProduct

Evaluation of proton MR spectroscopy at 3 Tesla without endorectal coil in patients with a localized prostate cancer treated with exclusive radiother…

2011

Prostate cancer is the most frequent tumour affecting the male population. When the prostate is not removed and is treated with radiation therapy, PSA slowly decreases over time to reach its nadir, even sometimes 18 to 24 months after the completion of radiation therapy without combined androgen suppression therapy. When combined with hormones, PSA falls abruptely with no possibility to perceive the impact of either hormones or radiation effects on PSA.The optimal value of PSA that should be reached after radiation therapy (nadir) and time to this nadir are still unclear.Even when a satisfactory value of the PSA nadir is reached, on-going variations of the PSA and its “bounce” effects, whic…

BiomarqueursRéponse thérapeutique[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyProstate cancerTherapeutic responseRadiotherapySpectroscopieCancer de la prostateIRM fonctionnelle[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyBiomarkersSpectroscopy[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyFunctional MRIRadiothérapie
researchProduct

Titanate nanotubes as versatile nanovectors : radiosensitizers for the treatment of prostate cancer and nuclear imaging probes

2017

Currently, the systemic injections of drugs reach very weakly tumor sites and large doses are thus administered causing adverse side effects. The new implementations of nanoparticles in the medical field offer new strategies to vectorize an active substance in diseased cells. This work is focused on the prostate cancer, which is the second most frequently diagnosed cancer and the fifth leading cause of cancer death in men worldwide.Titanate nanotubes (TiONts) are synthetized by a hydrothermal process and have average dimensions of about 170 nm in length, 10 nm in outer diameter and also have an internal cavity of 4 nm in diameter. Their needle-shaped morphology allows them to be internalize…

Prostate cancerRadiotherapySpect[CHIM.THER] Chemical Sciences/Medicinal ChemistryFonctionnalisation[ CHIM.THER ] Chemical Sciences/Medicinal Chemistry[CHIM.THER]Chemical Sciences/Medicinal ChemistryCancer de la prostateTitanate nanotubesDocétaxel[PHYS.PHYS.PHYS-CHEM-PH] Physics [physics]/Physics [physics]/Chemical Physics [physics.chem-ph][ PHYS.PHYS.PHYS-CHEM-PH ] Physics [physics]/Physics [physics]/Chemical Physics [physics.chem-ph][CHIM.RADIO] Chemical Sciences/Radiochemistry[PHYS.PHYS.PHYS-CHEM-PH]Physics [physics]/Physics [physics]/Chemical Physics [physics.chem-ph]Nanotubes de titanateFunctionalization[CHIM.RADIO]Chemical Sciences/Radiochemistry[ CHIM.RADIO ] Chemical Sciences/RadiochemistryRadiothérapie
researchProduct

Computer-Aided Diagnosis for Prostate Cancer using Multi-Parametric Magnetic Resonance Imaging

2016

Prostate cancer (CaP) is the second most diagnosed cancer in men all over the world.CaP growth is characterized by two main types of evolution: (i) the slow-growing tumours progress slowly and usually remain confined to the prostate gland; (ii) the fast-growing tumours metastasize from prostate gland to other organs, which might lead to incurable diseases.Therefore, early diagnosis and risk assessment play major roles in patient treatment and follow-up.In the last decades, new imaging techniques based on Magnetic Resonance Imaging (MRI) have been developed improving diagnosis.In practise, diagnosis can be affected by multiple factors such as observer variability and visibility and complexit…

Prostate cancermachine learningmp-MRIpattern recognitionmagnetic resonance imagingcomputer-aided diagnosis[ SPI.SIGNAL ] Engineering Sciences [physics]/Signal and Image processingCancer de la prostatemulti-parametric[SPI.SIGNAL]Engineering Sciences [physics]/Signal and Image processing[SPI.SIGNAL] Engineering Sciences [physics]/Signal and Image processing
researchProduct

Cancer et environnement : expertise collective

2008

Les cancers représentent en France la première cause de mortalité chez les hommes et la deuxième cause chez les femmes et figurent parmi les pathologies pouvant être liées à l’environnement. À la demande de l’Afsset, l’Inserm a réuni un groupe d’experts afin d’établir un bilan des connaissances sur les liens entre l’exposition à des facteurs physiques, chimiques ou biologiques présents dans l’atmosphère, l’eau, les sols ou l’alimentation et neuf types de cancers en augmentation au cours des vingt-cinq dernières années : les cancers du poumon, les mésothéliomes, les hémopathies malignes, les tumeurs cérébrales, les cancers du sein, de l’ovaire, du testicule, de la prostate etde la thyroïde. …

Tumeurs cérébrales[SDV.EE.SANT]Life Sciences [q-bio]/Ecology environment/HealthCancer de l'ovaireExposition aux agents chimiques et physiquesCancer de la thyroïdeMésothéliomeHémopathies malignesCancer du testiculeCancer de la prostate[ SDV.EE.SANT ] Life Sciences [q-bio]/Ecology environment/HealthToxicité[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieCancer du poumon[SDV.EE.SANT] Life Sciences [q-bio]/Ecology environment/Health[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieCancer du sein
researchProduct

Hypofractionnated radiotherapy for elderly patients with prostate cancer

2018

Radiation therapy technique and schedules could be adapted to patient's age because of a natural history of prostate cancer perceived as different, taking into account the comorbidities of patients but also a particular tolerance of elderly subjects. Thus, in localized prostate cancer, evaluation of associated diseases is essential before considering a treatment that will be of interest only if the life expectancy is greater than 10 years. When a curative approach is decided, radiotherapy holds a place of choice. Due to the recent results of randomized studies evaluating moderate hypofractionnated radiotherapy, showing a carcinological equivalence compared to a standard fractionation, this …

[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/ImagingFractionation SchedulesNon-InferiorityProstate[SDV.CAN]Life Sciences [q-bio]/Cancer[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicineRadiothérapie hypofractionnée Sujet âgé Cancer de la prostate OncogériatrieRadical ProstatectomyOlder MenGeriatric assessment[SDV.IB.MN] Life Sciences [q-bio]/Bioengineering/Nuclear medicineIntensity-Modulated RadiotherapyQuality-Of-LifeElderly patientsExpectancy[SDV.IB.IMA] Life Sciences [q-bio]/Bioengineering/Imaging[SDV.CAN] Life Sciences [q-bio]/CancerBeam Radiation-TherapyAndrogen-Deprivation TherapyHypofractionnated radiotherapyPhase-3 Chhip Trial
researchProduct